The superiorities of invasive procedures in nodal staging of non-small cell lung cancers

被引:0
|
作者
Enon, Serkan [1 ]
Tokat, Arif Osman [2 ]
Gungor, Adem [1 ]
机构
[1] Ankara Univ, Tip Fak, Gogus Cerrahisi Anabilim Dali, Ankara, Turkey
[2] SB Ankara Egitim & Arastirma Hastanesi, Ankara, Turkey
来源
关键词
Lung cancer; staging; N2;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The staging of non-small cell lung cancer is the most important factor that affects the treatment form and prognosis. The management strategy includes serious variations according to clinical condition of the patient, preoperative, intraoperative and postoperative pathologic staging outcomes. Today, obtaining the histopathological diagnosis preoperatively became mandatory. Reaching the definite tissue diagnosis requires the using of invasive technics. Nowadays; there is a widespread use of invasive staging and diagnostic procedures in order to show the evidence of disease presence and determine the probability of contralateral metastasis in a patient who will undergo a possible thoracotomy. In the preoperative period, benefiting from the invasive staging methods that will reveal occult N2 disease totally, would be more useful for the patients.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [21] Nodal micrometastasis in non-small cell lung cancer
    Passlick, B
    NEW ADVANCES IN THORACIC ONCOLOGY: FROM SCIENTIFIC EVIDENCE TO OPTIMAL MANAGEMENT, 2005, 350 : 55 - 61
  • [22] Mediastinal Staging in Non-Small Cell Lung Cancer
    Gamliel, Ziv
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 493 - +
  • [23] Surgical Staging for Non-Small Cell Lung Cancer
    Gamliel, Ziv
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (04) : 691 - +
  • [24] Mediastinal staging for non-small cell lung cancer
    Leiro-Fernandez, Virginia
    Fernandez-Villar, Alberto
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 496 - 505
  • [25] Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer
    Harris, Jeremy P.
    Nwachukwu, Chika
    Qian, Yushen
    Pollom, Erqi
    Loo, Billy W.
    Das, Millie
    Diehn, Maximilian
    LUNG CANCER, 2018, 124 : 76 - 85
  • [26] Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
    Farrell, MA
    McAdams, HP
    Herndon, JE
    Patz, EF
    RADIOLOGY, 2000, 215 (03) : 886 - 890
  • [27] Non-small cell lung carcinoma: Preoperative nodal staging and detection of recurrence with FDG-PET.
    Guhlmann, CA
    Storck, M
    Kocher, F
    Kotzerke, J
    Moog, F
    SunderPlassmann, L
    Reske, SN
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1119 - 1119
  • [28] Lymph nodal staging for non-small-cell lung cancer
    Jiwnani, Sabita
    Karimundackal, George
    Mehta, Marzi
    Pramesh, C. S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 42 (05) : 907 - 907
  • [29] Prostacyclin in human non-small cell lung cancers
    Nana-Sinkam, P
    Golpon, H
    Keith, RL
    Oyer, RJ
    Sotto-Santiago, S
    Moore, MD
    Franklin, L
    Nemenoff, RA
    Geraci, MW
    CHEST, 2004, 125 (05) : 141S - 141S
  • [30] Racial Disparities on the Use of Invasive and Noninvasive Staging in Patients with Non-small Cell Lung Cancer
    Suga, Jennifer Marie
    Nguyen, Danh V.
    Mohammed, Sandra M.
    Brown, Monica
    Calhoun, Royce
    Yoneda, Ken
    Gandara, David R.
    Lara, Primo N., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1772 - 1778